<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04961346</url>
  </required_header>
  <id_info>
    <org_study_id>Ultrapo-Studie</org_study_id>
    <nct_id>NCT04961346</nct_id>
  </id_info>
  <brief_title>RCT Comparing Lightweight vs. Heavyweight Meshes in Incisional Hernia Repair</brief_title>
  <official_title>Sublay Technique With Retromuscular Mesh Augmentation for Incisional Hernia Repair - A Prospective Randomized Multicentre Trial Comparing &quot;Lightweight&quot; Versus &quot;Heavyweight&quot; Meshes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomized, controlled, prospective multicentre clinical trial with a parallel group&#xD;
      design a large-pore, lightweight polypropylene mesh (Ultrapro®) is compared to a small-pore,&#xD;
      heavyweight polypropylene mesh (Premilene®), within a standardized, retromuscular mesh&#xD;
      augmentation to identify the superiority of the lightweight mesh. Included patients are&#xD;
      examined at five scheduled follow-up visits (5 and 21 days, 4, 12 and 24 months after&#xD;
      surgery). The primary outcome criterion is foreign body sensation 12 month after surgery.&#xD;
      Further secondary endpoint criteria are the occurrence of haematoma or haematoma requiring&#xD;
      surgery at the 5-day visit, seroma, wound infection, and chronic pain within 24 months&#xD;
      postoperatively. Quality of life was investigated by the SF-36®.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2004</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">June 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>foreign body sensation</measure>
    <time_frame>12 month after surgery</time_frame>
    <description>Quality of life measurement based on the occurrence of a foreign body sensation for more than 3 months within 12 month after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative seroma</measure>
    <time_frame>24 month</time_frame>
    <description>Fluid collection in the wound area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound infection</measure>
    <time_frame>24 month</time_frame>
    <description>Clinical identification of superficial and deep wound infections.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>haematoma</measure>
    <time_frame>5 days</time_frame>
    <description>hematoma in the wound area</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hematoma requiring surgery</measure>
    <time_frame>5 days</time_frame>
    <description>hematoma in the wound area requiring surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>chronic pain</measure>
    <time_frame>24 month</time_frame>
    <description>Chronic pain is defined as pain sensations that persist for more than 3 months after surgery. A Visual Analog Scale (VAS) with a range of 0-10 is used as a tool to measure pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hernia recurrence</measure>
    <time_frame>24 month</time_frame>
    <description>hernia recurrence is defined as a new abdominal wall defect in the area of surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">188</enrollment>
  <condition>Incisional Hernia</condition>
  <arm_group>
    <arm_group_label>Ultrapro®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received incisional hernia repair with an Ultrapro mesh in a sublay technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Premilene®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received incisional hernia repair with a Premilene mesh in a sublay technique.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrapro® mesh</intervention_name>
    <description>large-pore, lightweight polypropylene mesh</description>
    <arm_group_label>Ultrapro®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Premilene® mesh</intervention_name>
    <description>small-pore, heavyweight polypropylene mesh</description>
    <arm_group_label>Premilene®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  fascial defect after vertical midline laparotomy with a minimum of 4 cm in diameter&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  hernia of other location&#xD;
&#xD;
          -  recurrent hernia&#xD;
&#xD;
          -  incarcerated hernia&#xD;
&#xD;
          -  emergency surgery&#xD;
&#xD;
          -  patients with a malignancy or chemotherapy within the last 3 months&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  participation in other studies&#xD;
&#xD;
          -  patients with a wound infection&#xD;
&#xD;
          -  missing informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ralf D Hilgers, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Medical Statistics, RWTH Aachen University Hospital, Aachen, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Surgery, University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <state>NRW</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>June 16, 2021</study_first_submitted>
  <study_first_submitted_qc>July 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2021</study_first_posted>
  <last_update_submitted>July 16, 2021</last_update_submitted>
  <last_update_submitted_qc>July 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RWTH Aachen University</investigator_affiliation>
    <investigator_full_name>Andreas Kroh, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Incisional Hernia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

